Detecting BRCA1 and BRCA2 mutations via new, clinically validated diagnostic test
 

The recognition of a causal link between mutations in BRCA1 and BRCA2 genes and increased risk of developing breast and ovarian cancer has intensified the demand for genetic testing. Identifying mutations in these large genes by conventional methods can be time consuming and costly...

More...